These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2374694)
41. Myeloid differentiation primary response gene 88 (MyD88) deficiency in a large kindred. Conway DH; Dara J; Bagashev A; Sullivan KE J Allergy Clin Immunol; 2010 Jul; 126(1):172-5. PubMed ID: 20538326 [No Abstract] [Full Text] [Related]
42. Cloning and sequence analysis of the cDNA for murine interleukin-6. Grenett HE; Fuentes NL; Fuller GM Nucleic Acids Res; 1990 Nov; 18(21):6455. PubMed ID: 2243807 [No Abstract] [Full Text] [Related]
43. Germline gain-of-function myeloid differentiation primary response gene-88 (MYD88) mutation in a child with severe arthritis. Sikora KA; Bennett JR; Vyncke L; Deng Z; Tsai WL; Pauwels E; Layh-Schmitt G; Brundidge A; Navid F; Zaal KJM; Hanson E; Gadina M; Staudt LM; Griffin TA; Tavernier J; Peelman F; Colbert RA J Allergy Clin Immunol; 2018 May; 141(5):1943-1947.e9. PubMed ID: 29427642 [No Abstract] [Full Text] [Related]
44. MyD88: a central player in innate immune signaling. Deguine J; Barton GM F1000Prime Rep; 2014; 6():97. PubMed ID: 25580251 [TBL] [Abstract][Full Text] [Related]
45. The cloning and characterization of human MyD88: a member of an IL-1 receptor related family. Bonnert TP; Garka KE; Parnet P; Sonoda G; Testa JR; Sims JE FEBS Lett; 1997 Jan; 402(1):81-4. PubMed ID: 9013863 [TBL] [Abstract][Full Text] [Related]
46. ST2825, independent of MyD88, induces reactive oxygen species-dependent apoptosis in multiple myeloma cells. Nakamura H; Arihara Y; Usami M; Takada K Biochem Biophys Rep; 2024 Jul; 38():101681. PubMed ID: 38455592 [TBL] [Abstract][Full Text] [Related]
47. A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling. Li Y; Shah RB; Sarti S; Belcher AL; Lee BJ; Gorbatenko A; Nemati F; Yu H; Stanley Z; Rahman M; Shao Z; Silva JM; Zha S; Sidi S Sci Signal; 2023 Dec; 16(816):eadh3449. PubMed ID: 38113335 [TBL] [Abstract][Full Text] [Related]
48. Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825. Liu M; Kang W; Hu Z; Wang C; Zhang Y Inflamm Res; 2023 Nov; 72(10-11):2023-2036. PubMed ID: 37814128 [TBL] [Abstract][Full Text] [Related]
49. Incomplete Knockdown of MyD88 Inhibits LPS-Induced Lung Injury and Lung Fibrosis in a Mouse Model. Fan H; Wang Y; Zhao K; Su L; Deng C; Huang J; Chen G Inflammation; 2023 Dec; 46(6):2276-2288. PubMed ID: 37606850 [TBL] [Abstract][Full Text] [Related]
51. The TLR/MyD88 signalling cascade in inflammation and gastric cancer: the immune regulatory network of Helicobacter pylori. Liu M; Hu Z; Wang C; Zhang Y J Mol Med (Berl); 2023 Jul; 101(7):767-781. PubMed ID: 37195446 [TBL] [Abstract][Full Text] [Related]
53. Human variation in population-wide gene expression data predicts gene perturbation phenotype. Bonaguro L; Schulte-Schrepping J; Carraro C; Sun LL; Reiz B; Gemünd I; Saglam A; Rahmouni S; Georges M; Arts P; Hoischen A; Joosten LAB; van de Veerdonk FL; Netea MG; Händler K; Mukherjee S; Ulas T; Schultze JL; Aschenbrenner AC iScience; 2022 Nov; 25(11):105328. PubMed ID: 36310583 [TBL] [Abstract][Full Text] [Related]
54. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies. Idelfonso-García OG; Alarcón-Sánchez BR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; Villa-Treviño S; Muriel P; Serrano H; Pérez-Carreón JI; Arellanes-Robledo J Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453355 [TBL] [Abstract][Full Text] [Related]
55. Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia. Piazza F; Di Paolo V; Scapinello G; Manni S; Trentin L; Quintieri L Front Oncol; 2021; 11():801124. PubMed ID: 35087759 [TBL] [Abstract][Full Text] [Related]
58. MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity. Saikh KU Immunol Res; 2021 Apr; 69(2):117-128. PubMed ID: 33834387 [TBL] [Abstract][Full Text] [Related]
59. CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance. Montamat G; Leonard C; Poli A; Klimek L; Ollert M Front Immunol; 2021; 12():590054. PubMed ID: 33708195 [TBL] [Abstract][Full Text] [Related]
60. Going, Toll-like receptors in skin inflammation and inflammatory diseases. Kumar V EXCLI J; 2021; 20():52-79. PubMed ID: 33510592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]